Latest news with #FAAN
Zawya
21-04-2025
- Business
- Zawya
Nigeria: FG shuts Enugu Airport for emergency runway repairs
The Federal Government has declared the temporary shutdown of the Akanu Ibiam International Airport in Enugu, Enugu State, for emergency repairs of the runway. This announcement came shortly after Air Peace temporarily suspended flights due to alleged safety concerns. The Head of Corporate Communications, Air Peace, Dr. Ejike Ndiulo confirmed the decision in a statement and said that the Enugu Airline had been causing disturbance to Air Peace flights. The statement, according to the Corporate Communications Head, reads, 'We regret to inform you that all flights scheduled to Akanu Ibiam International Airport, Enugu are temporarily suspended due to safety concerns of the Enugu airport runway. 'The situation of the Enugu runway has been causing major disruptions to Air Peace flights, hence the decision to temporarily suspend further flights into this airport until further notice. 'At Air Peace, we prioritize Safety first over convenience. We believe that if flights are not operated into this aerodrome for the next few days, it will allow FAAN the opportunity to perform the necessary repairs on the runway. 'To this end, please be informed that all flights scheduled into and out of Enugu will now be operated into and out of Asaba airport. We regret any inconvenience this change might have caused. At Air Peace, your safety is our priority.' Meanwhile, Tribune Online reported the closure of the airway in 2019 for the same concerns with Air Peace throwing its weight behind the decision to shut down the runway. However, the runway that was repaired deteriorated again causing pilots to experience difficulties landing at the runway. Obiageli Orah, Director of Public Affairs and Consumer Protection at FAAN, in a statement, confirmed the shutdown and further stated that there was an abrupt and significant tear in the asphalt surface at a critical point of the runway. According to her, emergency repairs would begin from the ruptured point on the runway from April 22nd to May 6th, 2025. Her statement reads, 'In compliance with Nigerian civil aviation regulations, the Federal Airports Authority of Nigeria (FAAN) has, therefore, closed the runway during this period. 'As part of FAAN's commitment to passenger safety and the modernisation of airport facilities, the runway will not be open for landings or takeoffs during the rehabilitation period. 'FAAN appeals to all airport users and stakeholders for their understanding and cooperation during this time. All flights to this airport will be diverted to nearby airports. 'We sincerely apologise for the late and unexpected notice regarding this closure.'
Yahoo
04-04-2025
- Health
- Yahoo
American Nurses Enterprise Names New Chief Nursing Officer
Dr. Bradley Goettl, DNP, DHA, RN, FNP-C, FAAN appointed to enterprise leadership role SILVER SPRING, MD, April 04, 2025 (GLOBE NEWSWIRE) -- The American Nurses Enterprise, which includes the American Nurses Association, the American Nurses Credentialing Center, and the American Nurses Foundation, is pleased to announce the appointment of Bradley (Brad) Goettl, DNP, DHA, RN, FNP-C, FAAN as its new Chief Nursing Officer. Dr. Goettl will join the organization on April 21, 2025. 'It is a humbling and exciting opportunity to be the next Chief Nursing Officer and a member of the American Nurses Enterprise's executive team, advancing nursing professional practice standards for more than 5 million nurses,' notes Dr. Goettl. Most recently, Dr. Goettl served as the interim Co-Executive Director and Chief Clinical Officer of the Emergency Nurses Association. He has also contributed as the Director of Advanced Practice Provider Fellowships Programs at UT Southwestern Medical Center in Dallas, Texas. Brad holds a wide-range of specialty certifications reflecting his commitment to ongoing professional development and formal credentialing as an emergency nurse (CPEN) and emergency nurse practitioner (ENP-C), adult gerontology acute care nurse practitioner (AGACNP-BC), certified flight registered nurse (CFRN), and as an emergency medical technician – paramedic (EMT-P). He is also an appointed fellow of the American Association of Nurse Practitioners (FAANP), Academy of Emergency Nursing (FAEN), American College of Healthcare Executives (FACHE), and the American Academy of Nursing (FAAN). Earlier this year, he was appointed Nurse Executive in Residence at Georgetown University School of Nursing as part of a nationally recognized senior nurse leader advisory team to contribute to the school's Executive Doctor of Nursing Practice in Health System Leadership and Policy. 'Brad has an impressive professional nursing background, grounded through his career journey from EMT, RN and APRN, serving in progressive operational, association, policy advocacy and academic roles as a nationally recognized executive nurse leader,' says American Nurses Association's President Jennifer Mensik Kennedy, PhD, MBA, RN, NEA-BC, FAAN. 'Serving as an appointed commissioner for the Commission on Accreditation in Nursing Continuing Professional Development with the American Nurses Credentialing Center (ANCC) has positioned Brad to shape a wide range of future standards. I look forward to partnering with him in his new role as Chief Nursing Officer,' shares ANCC President Laura J. Wood, DNP, RN, NEA-BC, FAAN. 'Brad's forward-looking perspectives, unwavering passion, his contributions within membership associations and professional development programs, and his national and international perspectives make him a perfect fit for this strategic executive leadership role,' said American Nurses Enterprise Chief Executive Officer Angela Beddoe. 'The Chief Nursing Officer amplifies the shared priorities and advocates for unified solutions for all nurses.' ### About American Nurses Enterprise American Nurses Enterprise unites the expertise and dedication of the American Nurses Association, American Nurses Credentialing Center, and American Nurses Foundation to champion nurses, advance standards of excellence and inspire transformative change. With a powerful legacy and forward-thinking vision, our influence spans federal and local levels working through state affiliates and partners to amplify the voice of nurses across all practices and specialties. Every day, we harness The Power of Nurses™ to increase the value of the nursing profession and transform the healthcare experience for all. CONTACT: LaShondà Steward American Nurses Association +1 (301) 628.5321 in to access your portfolio
Associated Press
25-03-2025
- Health
- Associated Press
Apnimed to Host Virtual Investor Event Highlighting the Potential for AD109 as a Novel Pharmacotherapy for Obstructive Sleep Apnea on April 11, 2025
CAMBRIDGE, Mass., March 25, 2025 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company focused on discovery, development, and commercialization of first-in-class oral therapies that address the neuromuscular dysfunction of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced that it will host a virtual investor event on Friday, April 11, 2025 at 12:00 PM ET. To register, click here. The event will feature leading experts in sleep medicine, Douglas Kirsch, MD, FAAN, FAASM (Wake Forest University), and Nathaniel Watson, MD, MSc, FAAN, FAASM (University of Washington), who will provide an in-depth analysis of the unmet medical need in OSA and the shifting treatment paradigm. In addition, Apnimed will unveil new analyses exploring the potential impact of pharmacotherapies on the OSA treatment landscape, with a focus on AD109, Apnimed's investigational oral tablet designed to target the neuromuscular root cause of upper airway collapse in people with OSA. Apnimed's leadership team will also provide an update on its ongoing Phase 3 SynAIRgy and LunAIRo trials, and a preview of Apnimed's go-to-market strategy to unlock the blockbuster potential of AD109. Top-line results from Apnimed's Phase 3 SynAIRgy and LunAIRo clinical trials are expected in the second quarter of 2025 and the third quarter of 2025, respectively. A live question and answer session will follow the presentations and KOL discussion. About Douglas Kirsch, MD, FAAN, FAASM Dr. Kirsch is the Medical Director of Atrium Health Sleep Medicine, where he maintains an active clinical sleep practice and oversees clinical sleep medicine for the multi-state hospital system. He is currently a Clinical Professor in the Department of Neurology at the Wake Forest School of Medicine and was previously on the faculty at the University of Michigan Medical School and Harvard Medical School. He was the 2018-19 President of the American Academy of Sleep Medicine and was the Program Chair for the SLEEP Meeting in 2012-14 and the Chair of AASM Sleep Medicine Trends course from 2023-5. His current interests include emerging technology in Sleep Medicine and proving the value of Sleep Medicine care. About Nathaniel Watson, MD, MSc, FAAN, FAASM Dr. Watson is currently Professor and Vice Chair of Faculty Affairs in the Department of Neurology, Co-director of the Sleep Center, and Director of the Harborview Medical Center Sleep Clinic at the University of Washington. He holds certifications with the American Board of Psychiatry and Neurology, with a Sleep Medicine subspecialty, and the American Board of Sleep Medicine. Dr. Watson is a former President of the American Academy of Sleep Medicine and the American Board of Sleep Medicine. Over the course of his career he has held multiple research grants to study sleep disturbances and published extensively for medical and lay audiences. He has led the development of guideline and consensus documents regarding monitoring and managing sleep disturbances. His research has investigated genetic aspects of sleep duration and metabolic disease, mental health, and inflammation. His current investigations include the relationship between sleep and cancer risk, the impact of artificial intelligence and consumer sleep technology on human sleep and sleep medicine, and increasing access to sleep care for Native American populations. He is a passionate advocate for sleep health, with efforts focused on promoting healthy school start times, abolishment of daylight saving time, and transportation safety. His sleep advocacy and media work has touched millions of lives. Dr. Watson studied medicine at the University of North Carolina and obtained his master of science in genetic epidemiology from the University of Washington. He completed his medical internship, neurology residency, and clinical neurophysiology fellowship at the University of Washington. He has also conducted postgraduate studies at the National Institutes of Health and the University of Colorado. About AD109 AD109 could be the first pharmacological treatment to improve oxygenation during sleep by directly addressing the underlying neuromuscular cause of upper airway collapse in people with obstructive sleep apnea. It is a first-in-class combination of aroxybutynin, a novel antimuscarinic, and atomoxetine, a selective noradrenaline reuptake inhibitor (NRI). Their combined pharmacological synergy targets the root neuromuscular cause of OSA. AD109 is a once-nightly oral pill that is designed to lower the complexity of intervention and may help more people benefit from effective, restorative sleep. In a disease characterized by complex and invasive treatment options, AD109 may be a simple solution to help improve oxygenation and health wellbeing for people living with OSA. About Obstructive Sleep Apnea Obstructive sleep apnea is a serious chronic sleep-related breathing disease where the upper airway repeatedly collapses during sleep, causing intermittent oxygen deprivation. It is caused by two overlapping mechanisms: neuromuscular dysfunction during sleep and predisposing anatomic abnormalities. The impact of OSA spans age, sex, and body type—there is no single face of the disease. Every night, greater than 54 million people in the U.S. and 1 billion people worldwide with OSA intermittently stop breathing, exposing them to serious, long-term health risks. An individual with OSA can experience hundreds of these sleep apnea events in a single night. Each sleep apnea event reduces blood oxygen levels and deprives cells of the energy they need to perform vital functions. Ultimately, failure to effectively treat OSA increases the risk of long-term health consequences and quality of life impacts, including daytime fatigue, impaired judgement, premature death, and severe and potentially life-threatening health complications, such as high blood pressure, cardiovascular disease, and type 2 diabetes. Yet, even after being diagnosed, the majority of people with OSA either refuse, abandon, or underutilize treatment. In addition, no currently available treatments address the underlying neuromuscular dysfunction present in all OSA cases. About Apnimed Apnimed is a pharmaceutical company dedicated to breathing new life into the sleep-related breathing disease treatment landscape. The company envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment, and elevate the health and expectations of everyone in the sleep-related breathing disease community. Based in Cambridge, Mass., Apnimed is advancing a focused pipeline of oral pharmaceutical product candidates designed to help improve oxygenation for people living with obstructive sleep apnea and beyond, to other sleep-related breathing diseases, including several that are part of our joint venture with Shionogi & Co., Ltd, Shionogi Apnimed Sleep Science (SASS). Learn more at or follow us on X and LinkedIn. Media Contact:
Zawya
13-02-2025
- Business
- Zawya
Nigeria signs amended BASA agreement with UAE
Nigeria's Minister of Aviation and Aerospace Development, Festus Keyamo, has signed the amended Bilateral Air Service Agreement (BASA) between Nigeria and the United Arab Emirates (UAE). The landmark agreement was executed during the International Civil Aviation Organization (ICAO) Global Implementation Support Symposium (GISS) 2025, in a high-level meeting with UAE's Minister of Economy, H.E. Abdulla Bin Touq Al Marri, solidifying mutual aviation ties between both nations. Accompanying the Honourable Minister as part of the Nigerian delegation were, Capt. Chris Ona Najomo, Director General, Nigerian Civil Aviation Authority (NCAA), Mrs. Olubunmi Kuku, Managing Director, Federal Airports Authority of Nigeria (FAAN), Mrs. Olayinka T. Babaoye-Iriobe, Director, Air Transport Regulations, NCAA, Capt. Abdullahi Mahmood, Director of Operations, FAAN and Mr. Ahmed Tijani, Director, Air Transport Management, Ministry of Aviation and Aerospace Development. The ICAO GISS 2025, hosted by H.E. Saif Mohammed Al Suwaidi, Director General of the UAE General Civil Aviation Authority (GCAA), brought together over 35 ministers, 191 countries, 1,500 aviation professionals, and 70 exhibitors at the prestigious Emirates Palace, Mandarin Oriental, Abu Dhabi. The event also featured the Global Sustainable Aviation Marketplace (GSAM)—an ambitious initiative by the UAE to drive collaboration and innovation in sustainable aviation. The signing of the amended BASA, according to the special adviser to the minister on media and communications, Tunde Moshood, built on last year's negotiations, ensuring reciprocal rights for both countries and fostering deeper aviation collaboration. At the event, the Minister emphasized the importance of enhancing connectivity between Nigeria and the UAE, with a focus on expanding codeshare agreements and interlining opportunities for Nigerian airlines. During the signing ceremony, H.E. Abdulla Bin Touq Al Marri lauded Nigeria's aviation minister saying: 'let me say this on camera now, the Nigeria aviation minister is a man who keeps his words and for us, that's everything', acknowledging his commitment to advancing Nigeria-UAE aviation relations. In a further boost to bilateral relations, both countries agreed to sign a Technical Cooperation Agreement focusing on capacity building and technical support in key aviation areas, including safety and regulatory, environment, airport facilitation and security. This cooperation reinforces Nigeria's commitment to elevating its aviation sector to global best practices while deepening ties with international partners. The Minister reaffirmed Nigeria's readiness to work closely with the UAE to implement these agreements effectively, ensuring that both nations maximiSe the economic and operational benefits of this strengthened partnership.
Associated Press
29-01-2025
- Health
- Associated Press
American Nurses Association Releases the Revised Code of Ethics for Nurses
SILVER SPRING, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Today, the American Nurses Association (ANA) Center for Ethics & Human Rights released the highly anticipated 2025 revision of the Code of Ethics for Nurses ( Code). For more than 60 years, the Code of Ethics for Nurses has been the cornerstone of ethical nursing practice providing guidance and instruction to effectively and honorably carry out the ethical responsibilities required of the nursing profession. In its latest update, over 6,000 nurses worldwide shared their insights to ensure it reflects today's realities. A panel of 49 experts, including six co-chairs, spent more than 600 hours refining the Code to address key issues like health disparities, racism, allyship, workplace safety, and emerging technologies, keeping the Code relevant and guiding nurses through the complexities of modern healthcare. Some of the key updates introduced include: Global Health Commitment: A new 10th provision affirms nursing's role in advancing human and environmental well-being worldwide. Confronting Structural Oppression: The Code now identifies racism as a public health crisis and acknowledges intersectionality in healthcare. Redefining Duty: Self-care and patient care are inseparable—nurses' well-being directly benefits those they serve. 'It is the tremendous responsibility and honor held by the American Nurses Association to maintain the Code of Ethics for Nurses. The Code is the social commitment from nurses to the public that we will uphold the ethical responsibility of our profession in pursuit of the health of our patients,' said Liz Stokes, PhD, JD, RN, director at the ANA Center for Ethics & Human Rights. 'The Code was revised to guide the nurses of today and tomorrow who exemplify our profession's moral duty to provide and advocate for safe, quality, and compassionate care for all patients and communities.' For 23 years, the American public has ranked nursing the ' Most Honest and Ethical Profession ' among other notable professions such as medical doctors, engineers, and veterinarians. 'The Code of Ethics for Nurses is a living, breathing body of work that is exercised and interpreted by nurses every day in all they do. Whether in the boardroom or at the bedside, the Code is a necessary instrument for practice, policy, and standards in all facets of nursing,' said American Nurses Association's President Jennifer Mensik Kennedy, PhD, MBA, RN, NEA-BC, FAAN. 'The power of nurses and the phrase 'nursing is a calling,' is true. The identity of being a nurse permeates our very being and all that we do—be it as caretakers, advocates, or educators—we are dedicated to delivering healthcare for all.' To provide better understanding of the Code 's foundational values and relational structure, ANA has released peer-reviewed, continuing nursing education (CNE) accredited courses for the first three provisions, with the remaining modules to be released throughout 2025. To access the revised Code of Ethics for Nurses, visit About American Nurses Association The American Nurses Association is the only association that represents and serves as the professional home for all registered nurses in every specialty and practice setting. We believe nurses are the heartbeat of healthcare. It is our calling to champion nurses and the causes they care about by working for improved work environments, top-notch education, smarter policies, and stronger partnerships. We advocate to amplify nurses' roles, their voices, and their value across healthcare and in society. The American Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
